De Luca Giuseppe, Nardin Matteo, Micari Antonino, Kedhi Elvin, Galasso Gennaro, Verdoia Monica
Department of Clinical and Experimental Medicine, Division of Cardiology, Policlinico G Martino, University of Messina, 98125 Messina, Italy.
Division of Cardiology, IRCCS Hospital Galeazzi-Sant'Ambrogio, 20157 Milan, Italy.
J Clin Med. 2025 Feb 19;14(4):1371. doi: 10.3390/jcm14041371.
. Despite the achievement of therapeutic goals regarding low-density lipoprotein cholesterol (LDL-C) levels with statins, high residual risk of events was reported in patients with coronary artery disease (CAD). Widespread attention has recently been focused on low plasmatic levels of high-density lipoproteins (HDLs) and high levels of triglycerides as risk factors for cardiovascular disease and as potential pharmacological targets, with particular attention paid to their ratio. Therefore, the aim of the current study was to investigate the association between triglycerides and HDLs and the TG/HDL ratio and their association with the prevalence and extent of CAD. . We included patients undergoing non-urgent coronary angiography at Azienda Ospedaliera-Universitaria "Maggiore della Carità", Novara, Italy, from 2007 to 2018. Patients chronically treated with triglyceride-lowering therapies (PUFA and Fibrates) were excluded from this analysis. Fasting samples were collected at the moment of angiography. CAD was defined as at least one vessel stenosis >50%. . Our study population of 5997 patients was divided according to TG/HDL ratio quartiles. The TG/HDL ratio was significantly associated with age, gender, smoking status, hypercholesterolemia, diabetes, and the chronic use of ACE inhibitors, statins, beta-blockers, aspirin, ADP antagonists, and diuretics. The TG/HDL ratio was additionally associated with several laboratory parameters. In multiple logistic regression analysis, HDLs but not the TG/HDL ratio were independently associated with the prevalence and extent of CAD. . Our study showed that HDLs but not the TG/HDL ratio are independently associated with the extent and prevalence of CAD. Therefore, this ratio does not provide additional prognostic information to HDLs in the prediction of the prevalence and extent of this disease.
尽管他汀类药物在降低低密度脂蛋白胆固醇(LDL-C)水平方面实现了治疗目标,但冠状动脉疾病(CAD)患者仍有较高的事件残留风险。近年来,血浆高密度脂蛋白(HDL)水平低和甘油三酯水平高作为心血管疾病的危险因素和潜在的药物靶点受到了广泛关注,尤其关注它们的比值。因此,本研究的目的是探讨甘油三酯与HDL之间的关联以及甘油三酯/HDL比值与CAD的患病率和病变程度之间的关系。
我们纳入了2007年至2018年在意大利诺瓦拉市“马焦雷慈善”大学医院接受非紧急冠状动脉造影的患者。长期接受降甘油三酯治疗(多不饱和脂肪酸和贝特类药物)的患者被排除在本分析之外。在血管造影时采集空腹样本。CAD定义为至少一支血管狭窄>50%。
我们的5997名患者研究人群根据甘油三酯/HDL比值四分位数进行划分。甘油三酯/HDL比值与年龄、性别、吸烟状况、高胆固醇血症、糖尿病以及ACE抑制剂、他汀类药物、β受体阻滞剂、阿司匹林、ADP拮抗剂和利尿剂的长期使用显著相关。甘油三酯/HDL比值还与几个实验室参数相关。在多因素逻辑回归分析中,HDL而非甘油三酯/HDL比值与CAD的患病率和病变程度独立相关。
我们的研究表明,HDL而非甘油三酯/HDL比值与CAD的病变程度和患病率独立相关。因此,在预测该疾病的患病率和病变程度时,该比值并未为HDL提供额外的预后信息。